Schwab Andrew J. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$2.55M

Insider Activity of Schwab Andrew J.

According to the SEC Form 4 filings, Schwab Andrew J., being in a position of

  1. director at CAMP4 Therapeutics Corporation,
    оver the last 12 months, has bought 0 shares, and sold 591875 shares for $2.5M,
    over all time since 2026-08-19, has bought 0 shares, and sold 591875 shares for $2.5M.

Biography of Schwab Andrew J.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$2,755,45611100

Comparison of Insiders on Amount of Buys and Sells

2026-09-23SaleSkye Bioscience, Inc.
SKYE
4,528
0.0922%
$1.61$7,290-11.67%
2026-09-22SaleSkye Bioscience, Inc.
SKYE
28,700
0.6107%
$1.65$47,355-6.73%
2026-09-16SaleSkye Bioscience, Inc.
SKYE
33,892
0.8668%
$1.91$64,734-5.59%
2026-08-27SaleCAMP4 Therapeutics Corporation
CAMP
director
400,000
0.6738%
$4.04$1.62M-7%
2026-08-24SaleCAMP4 Therapeutics Corporation
CAMP
director
10
<0.0001%
$4.50$45-10.19%
2026-08-21SaleCAMP4 Therapeutics Corporation
CAMP
director
32,018
0.1514%
$4.50$144,081-12.95%
2026-08-20SaleCAMP4 Therapeutics Corporation
CAMP
director
114,700
0.5497%
$4.54$520,738-12.44%
2026-08-20SaleSkye Bioscience, Inc.
SKYE
7,700
0.025%
$0.32$2,464-25%
2026-08-19SaleCAMP4 Therapeutics Corporation
CAMP
director
45,147
0.2176%
$4.76$214,900-15.91%
2026-08-19SaleSkye Bioscience, Inc.
SKYE
68,140
0.2218%
$0.35$23,849-31.43%
2026-08-18SaleSkye Bioscience, Inc.
SKYE
300,000
0.9036%
$0.38$114,000-41.46%
2025-08-22SaleSkye Bioscience, Inc.
SKYE
170,449
1.6463%
$3.42$582,936-74.81%
2025-08-21SaleSkye Bioscience, Inc.
SKYE
60,956
0.6146%
$3.57$217,613-76.65%
2024-09-13SaleSkye Bioscience, Inc.
SKYE
13,837
0.2368%
$6.06$83,852-46.5%
2024-09-11SaleSkye Bioscience, Inc.
SKYE
252,500
4.7065%
$6.60$1.67M-49.13%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.